Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation

Blood

Volumn 114, Issue 18, 2009, Pages 3813-3821

  Göbel, Florian ^a   Taschner, Sabine ^a   Jurkin, Jennifer ^a   Konradi, Sabine ^a   Vaculik, Christine ^b   Richter, Susanne ^a   Kneidinger, Doris ^a   Mühlbacher, Christina ^a   Bieglmayer, Christian ^c   Elbe Bürger, Adelheid ^b   Strobl, Herbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD11B ANTIGEN; CD14 ANTIGEN; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 4; NERVE GROWTH FACTOR RECEPTOR; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTOR GATA 1; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; GATA1 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DENDRITIC CELL; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LANGERHANS CELL; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; CELL STRAIN K 562; CELL STRAIN U937; CYTOLOGY; DRUG EFFECT; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; MYELOID PROGENITOR CELL;

ANTIGENS, CD14; CELL DIFFERENTIATION; DENDRITIC CELLS; GATA1 TRANSCRIPTION FACTOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-4; K562 CELLS; MONOCYTES; MYELOID PROGENITOR CELLS; RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; U937 CELLS;

EID: 70449700022     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-210484     Document Type: Article

References (47)

1. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109-1118.
2. Strobl H, Riedl E, Scheinecker C, et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol. 1996;157(4):1499-1507.
3. Strobl H, Bello-Fernandez C, Riedl E, et al. flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood. 1997;90(4):1425-1434.
4. Caux C, Vanbervliet B, Massacrier C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GMCSF +TNF alpha. J Exp Med. 1996;184(2):695-706.
5. Ratzinger G, Baggers J, de Cos MA, et al. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol. 2004;173(4):2780-2791.
6. Jaksits S, Kriehuber E, Charbonnier AS, Rappersberger K, Stingl G, Maurer D. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J Immunol. 1999;163(9):4869-4877.
7. Caux C, Massacrier C, Dubois B, et al. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol. 1999;66(5):781-791.
8. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med. 1998;187(6):961-966.
9. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med. 1996;184(6):2417-2422.
10. Borkowski TA, Letterio JJ, Mackall CL, et al. A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J Clin Invest. 1997;100(3):575-581.
11. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med. 2007;204(11):2545-2552.
12. Taschner S, Koesters C, Platzer B, et al. Downregulation of RXRalpha expression is essential for neutrophil development from granulocyte/ monocyte progenitors. Blood. 2007;109(3):971-979.
13. van Etten E, Mathieu C. Immunoregulation by 1.25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97(1-2):93-101.
14. Gutierrez L, Nikolic T, van Dijk TB, et al. Gata1 regulates dendritic-cell development and survival. Blood. 2007;110(6):1933-1941.
15. Platzer B, Jorgl A, Taschner S, Hocher B, Strobl H. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood. 2004;104(12):3655-3663.
16. Jorgl A, Platzer B, Taschner S, et al. Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB. Blood. 2007;109(1):185-193.
17. Heinz LX, Platzer B, Reisner PM, et al. Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. Blood. 2006;107(4):1445-1453.
18. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 1997;15(9):871-875.
19. Platzer B, Richter S, Kneidinger D, Waltenberger D, Woisetschlager M, Strobl H. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J Immunol. 2009;183(1):66-74.
20. Klechevsky E, Morita R, Liu M, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity. 2008;29(3):497-510.
21. Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003;170(11):5382-5390.
22. Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol. 1991;97(2):230-239.
23. Bourguet W, Andry V, Iltis C, et al. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis. Protein Expr Purif. 2000;19(2):284-288.
24. Shiau AK, Barstad D, Loria PM, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998;95(7):927-937.
25. Berer A, Stockl J, Majdic O, et al. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol. 2000;28(5):575-583.
26. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000;270(3):701-708.
27. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164(5):2405-2411.
28. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 2000;164(9):4443-4451.
29. Wollenberg A, Mommaas M, Oppel T, Schottdorf EM, Gunther S, Moderer M. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol. 2002;118(2):327-334.
30. Ueno H, Klechevsky E, Morita R, et al. Dendritic cell subsets in health and disease. Immunol Rev. 2007;219:118-142.
31. Migliaccio AR, Rana RA, Sanchez M, et al. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med. 2003;197(3):281-296.
32. Yu C, Cantor AB, Yang H, et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med. 2002;195(11):1387-1395.
33. d'Ostiani CF, Del Sero G, Bacci A, et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med. 2000;191(10):1661-1674.
34. Kelleher P, Maroof A, Knight SC. Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol. 1999;29(7):2309-2318.
35. Maroof A, Penny M, Kingston R, et al. Interleukin-4 can induce interleukin-4 production in dendritic cells. Immunology. 2006;117(2):271-279.
36. Hural JA, Kwan M, Henkel G, Hock MB, Brown MA. An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells. J Immunol. 2000;165(6):3239-3249.
37. Kwan M, Powell DR, Nachman TY, Brown MA. An intron GATA-binding site regulates chromatin accessibility and is essential for IL-4 gene expression in mast cells. Eur J Immunol. 2005;35(4):1267-1274.
38. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999;13(11):1398-1411.
39. Zhang P, Behre G, Pan J, et al. Negative crosstalk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci U S A. 1999;96(15):8705-8710.
40. Nerlov C, Querfurth E, Kulessa H, Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood. 2000;95(8):2543-2551.
41. Ellison TI, Eckert RL, MacDonald PN. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. J Biol Chem. 2007;282(15):10953-10962.
42. Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 2002;23(12):2103-2109.
43. Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R. Correction of the abnormal mineral ion homeostasis with a highcalcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). Bone. 2003;32(4):332-340.
44. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
45. Holick MF. The use and interpretation of assays for vitamin D and its metabolites. J Nutr. 1990;120 Suppl 11:1464-1469.
46. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic cells. Blood. 2003;102(9):3314-3316.
47. Sigmundsdottir H, Pan J, Debes GF, et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol. 2007;8(3):285-293.